Omnibus IV military medical research and development

Active Awarded Last action

Contract number
HT001122D0022
Awardee
Awarding agency
Task orders
9 $20,834,205 obligated

Award facts

Opportunity
Combined order value
$24,499,614 Current and potential, with all options
Last date to order 44% complete
IDV ceiling <1% used
$10,000,000,000.00
Award type
Multiple award
Who can order
Defense agencies
Set-aside
No set-aside
Competition
Full and Open Competition · 126 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded an indefinite-delivery contract to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. on June 20, 2022, with a ceiling of $10 billion for military medical research and development services under the Omnibus IV program. This is a multiple-award IDIQ with an ultimate completion date of June 19, 2032, carrying no set-aside restrictions.

Place of performance encompasses domestic and international locations, with recent delivery orders performed at Westlake, Maryland; Frederick, Maryland; and Falls Church, Virginia. The originating solicitation, posted November 13, 2020, sought providers to deliver military medical research and development, clinical studies, infectious disease countermeasures, healthcare technology development, and supporting services to the Department of Defense and related federal agencies.

The contract carries a base period through June 19, 2032. Recent delivery order activity issued under this IDIQ reflects broad customer engagement across military medical research priorities. The Uniformed Services University of the Health Sciences issued orders for development of clinical practice guidelines supporting infectious disease care ($11.1 million, September 2024, through December 2026); drug screening for radiation combined injury in mice ($767,795, July 2024, through July 2027); medical countermeasures for radiation-induced lethality ($330,343, July 2024, through July 2025); IL-18 inhibitors for radiation-induced gastrointestinal syndrome ($126,502, July 2024, through July 2027); cutaneous radiation injury countermeasures ($858,105, July 2024, through July 2027); and radiation countermeasure mitigation evaluation ($876,213, July 2024, through July 2027). The Defense Health Agency issued orders for toxicology research support services ($4.1 million, July 2024, through June 2027) and digital twin research support services ($6.3 million, June 2024, through June 2027, with University of Connecticut subcontracted for digital twins solutions). A small order for military medical research and development services ($2,500, June 2023) rounded out recent activity.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00005 · Omnibus IV military medical research and development services $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00002 · Omnibus IV indefinite delivery indefinite quantity contract for military medical research and development services $0
Other Administrative Action P00001 $0
Original award $0

Subawards

Subcontractor Amount Awarded
University Of Connecticut DIGITAL TWIN RESEARCH SUPPORT SERVICES Supporting digital twins solutions for performance, health and diagnostics $189,599

Quick answers

Who was awarded contract HT001122D0022?

HT001122D0022 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by Defense Health Agency (Department of Defense) on June 20, 2022.

How much is contract HT001122D0022 worth?

Orders under HT001122D0022 have obligated $20,834,205. Their combined current value, with exercised options, is $24,499,614. HT001122D0022's own ceiling is $10,000,000,000.

How many orders have been placed under contract HT001122D0022?

9 orders have been placed under HT001122D0022, the latest on September 30, 2024.

Who can order from contract HT001122D0022?

HT001122D0022 is a multiple award indefinite delivery contract. Defense agencies can place orders on it.

Is contract HT001122D0022 part of a contract vehicle?

Yes. HT001122D0022 is part of Omnibus IV Military Medical Research And Development (OMNIBUS IV).

Was contract HT001122D0022 competed?

The extent of competition for HT001122D0022 was full and open competition. The government received 126 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV